Purchase Order 75F40123P00450
Award Date 9/25/23
Potential Completion Date 11/27/23
Potential Value $18K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $17,500 firm fixed price purchase order to Life Technologies Corporation for the purchase of anti-anthrax toxin antibody Obiltoxaximab in single glass vials at a concentration of 10 mg/ml. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation Financial Services Division and will deliver the requested product from its facility in Silver Spring, Maryland by November 9, 2023 to support the...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $15,985 firm fixed-price Blanket Purchase Agreement (BPA) call on March 9, 2016, by a civilian federal agency to supply drugs and biologicals. The contract, which was not subject to any set-aside designation, reflects Life Technologies' established position as a competitive supplier of specialized biotechnology products and services. The award is associated with Life Technologies' broader federal contracting...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a contract award valued at $12,880 for the procurement of drugs and biologicals from a civilian federal agency. The contract was awarded on November 19, 2015, under a Blanket Purchase Agreement (BPA) call mechanism with a firm fixed price structure and an ultimate completion date of November 29, 2015. The place of performance is located in Bethesda, Maryland. No set-aside designation was applied to this award,...
- This $107,400.00 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the provision of bio material supplies to support NIAID's research and healthcare missions. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools to federal...
- This federal contract award was made by the Office of the Director, a civilian agency, to Life Technologies Corporation, doing business as Thermo Fisher Scientific, a prominent manufacturer of scientific instruments, reagents, and consumables. The $10,483.20 firm fixed price contract is for the provision of drugs and biologicals, with an ultimate completion date of April 30, 2015. The contract does not have a set-aside designation, indicating Life Technologies' competitive position in federal...
- The Department of Health and Human Services Food and Drug Administration awarded a $25,000 firm fixed price purchase order to Life Technologies Corporation for cell line engineering services utilizing the Invitrogen FLP-IN 293 cell line. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation Financial Services Division and will perform the services in Silver Spring, Maryland. The contract runs from August 31, 2023 through August 30, 2024 to provide the FDA with cell line...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a $12,915.78 firm fixed price BPA call award from the Office of Logistics and Acquisition Operations (a civilian federal agency) for drugs and biologicals on April 4, 2017, with completion targeted for April 30, 2017. The contract was performed in Frederick, Maryland, and carried no set-aside designation, reflecting the contractor's competitive positioning in federal procurement. This award was issued as a task...
- Life Technologies Corporation, operating under the Thermo Fisher Scientific brand, received a $10,993.50 firm fixed-price Blanket Purchase Agreement (BPA) call award from the Office of Logistics and Acquisition Operations for drugs and biologicals on April 5, 2016, with completion scheduled for April 30, 2016. The contract was performed in Carlsbad, California and was awarded without a set-aside designation. This award represents a task order under an existing BPA vehicle, consistent with Life...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a $10,304.40 firm fixed-price contract award on April 4, 2017, from the Office of Logistics and Acquisition Operations for drugs and biologicals. The award was made as a call under an existing Blanket Purchase Agreement, with performance to be completed by April 30, 2017, at the contractor's facility in Carlsbad, California. No set-aside designation was applied to this award, reflecting the contractor's...
- This federal contract award is for $5,995.00 to Life Technologies Corporation, doing business as Thermo Fisher Scientific, to provide drugs and biologicals. The award is a Blanket Purchase Agreement (BPA) Call with a firm fixed price pricing type. The funding agency is the Office of the Director, a civilian agency. The place of performance is Bethesda, MD. There is no set-aside designation for this award. Life Technologies Corporation is the prime contractor, and its parent company is Thermo...
The Department of Health and Human Services Food and Drug Administration awarded a $17,500 firm fixed price purchase order to Life Technologies Corporation for the purchase of anti-anthrax toxin antibody, raxibacumab, in single glass vials at a concentration of 10 mg/ml. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation Financial Services Division and will deliver the contracted products from its facility in Silver Spring, Maryland by November 27, 2023 to support the FDA's regulatory and public health programs. No set aside designation or subcontracting details were provided in the award information.
Generated 12/17/23, 2:26 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 10/13/23 | |
| Not listed | Not listed | $17.5k | 9/25/23 |